Interesting times ahead, page-92

we have $2901k in the bank
add $840k we will receive this year (approx) for our r&d tax refund

that leaves us with $3,700k

in the 4c the estimated cash outflow for next quarter is $750k, I'll add a contingency of $150k to make it $900k.
subtract takings of $380k. = a deficit of $520k

that gives us 7 quarters of cash flow.

how much will the genetic spot pen add to the next 4c ?
will we release more products this year? I think so.

we may need a cr to fund a project like bodyguard, but that won't be needed for a while and will be at a higher sp than now.

of course, imho !!!!